Characterisation of parathyroid hormone concentration in extremely preterm or very low birthweight infants in routine clinical screening for metabolic bone disease: A service evaluation cohort study
Journal of Paediatrics and Child Health · 2023
DOI: 10.1111/jpc.16470 ↗At a glance
Kohortenstudie in Journal of Paediatrics and Child Health, 2023. Written by Ilana Levene and 6 co-authors. Institution: Newborn Care Unit, John Radcliffe Hospital, Oxford, United Kingdom. Major MEDLINE topics: Parathyroid Hormone, Bone Diseases, Metabolic, Neonatal Screening, Infant, Very Low Birth Weight. 21 references.
Abstract (original language)
Aim
To characterise parathyroid hormone (PTH) concentrations in infants at high risk for metabolic bone disease, in order to assist clinical decisions around the use of PTH for screening.
Methods
Infants born under 28 weeks' postmenstrual age or with birthweight under 1.5 kg in a tertiary neonatal unit in the UK were included. Clinical guidance was to assess PTH concentration in the first 3 weeks after birth. Clinical information was extracted from prospective records.
Results
Sixty‐four infants had mean birth gestation of 26 weeks and birthweight of 882 g. Median PTH (sent on median day 18 of life) was 9.2 pmol/L (interquartile range 5.3–17 pmol/L). Sixty‐seven per cent of infants had a PTH greater than 7 pmol/L. For 22% of the infants, raised PTH was not accompanied by abnormal phosphate or alkaline phosphatase. Eighty‐nine per cent of infants tested were insufficient or deficient for 25‐hydroxyvitamin D.
Conclusions
Universal screening highlights the high frequency of high PTH in this high‐risk population, implying a need for calcium supplementation. A considerable number of infants would not be identified as showing potential signs of metabolic bone disease if the assessment excludes the use of PTH. The high level of 25‐hydroxyvitamin D deficiency may be a confounder.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Newborn Care Unit, John Radcliffe Hospital, Oxford, United Kingdom.
- Pharmacy Department, John Radcliffe Hospital, Oxford, United Kingdom.
- Biochemistry Department, John Radcliffe Hospital, Oxford, United Kingdom.
- Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
ORCID profiles: Ilana Levene
Cite
APA
Levene, I., Dhami, A., Moreno, M., Shine, B., Chinoy, A., Padidela, R., & Molnar, Z. (2023). Characterisation of parathyroid hormone concentration in extremely preterm or very low birthweight infants in routine clinical screening for metabolic bone disease: A service evaluation cohort study. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16470
Vancouver
Levene I, Dhami A, Moreno M, Shine B, Chinoy A, Padidela R, et al. Characterisation of parathyroid hormone concentration in extremely preterm or very low birthweight infants in routine clinical screening for metabolic bone disease: A service evaluation cohort study. Journal of Paediatrics and Child Health. 2023. doi:10.1111/jpc.16470
BibTeX
@article{Levene2023,
author = {Levene, Ilana and Dhami, Amraj and Moreno, Mar and Shine, Brian and Chinoy, Amish and Padidela, Raja and Molnar, Zoltan},
title = {Characterisation of parathyroid hormone concentration in extremely preterm or very low birthweight infants in routine clinical screening for metabolic bone disease: A service evaluation cohort study},
journal = {Journal of Paediatrics and Child Health},
year = {2023},
doi = {10.1111/jpc.16470}
}
EUVIMED